文献速递重症综合管理与镇静镇痛

内科重症患者医源性阿片戒断综合征的患病率与危险因素

Prevalence and Risk Factors for Iatrogenic Opioid Withdrawal in Medical Critical Care Patients.
PubMed 文献 · Crit Care Explor · 2023-05-03
一句话结论内科ICU持续阿片输注≥24小时者约1/8发生中度及以上医源性阿片戒断,输注≥72小时或芬太尼日总量≥1200 μg者风险更高,停药时应监测。

该前瞻性观察研究纳入92例接受持续阿片输注≥24小时的内科ICU成人患者,停药后每天用COWS和DSM-V标准评估最多5天。11例(12%)发生中度及以上医源性阿片戒断综合征(IWS);IWS阳性组右美托咪定(38.3% vs 15.6%,p=0.014)和苯二氮䓬类(63.8% vs 37.8%,p=0.021)联用比例更高。逻辑回归显示持续阿片输注≥72小时和日总量≥1200 μg为独立预测因素。作者认为对这类患者停用阿片输注时应进行监测。

要点

  • 内科ICU持续阿片输注≥24小时的成人患者中,11例(12%)发生中度及以上IWS(COWS评定)。
  • 按DSM-V标准或任何严重程度IWS计算,约每3例中有1例被诊断(原文结论)。
  • IWS阳性组右美托咪定使用38.3% vs 阴性组15.6%(p=0.014),苯二氮䓬类63.8% vs 37.8%(p=0.021)。
  • 持续阿片输注≥72小时与日总量≥1200 μg(约50 μg/hr芬太尼)为IWS独立预测因素。
  • 停药后按需或定期阿片使用在两组间无显著差异。

适用人群与场景

  • 成人内科ICU患者,接受持续阿片输注≥24小时;研究在三级医院内科ICU进行。
  • 排除情况:447例接受≥24小时持续阿片治疗者中排除385例,最终纳入92例(原文未逐条列出排除原因)。

诊断标准与关键阈值

  • 使用临床阿片戒断量表(COWS)评估戒断严重程度,主要终点为中度及以上IWS。
  • 使用DSM-V阿片戒断标准判断IWS诊断。
  • 停药后每天评估,最多5天。

研究设计与关键结果

  • 前瞻性观察研究,92例内科ICU成人患者,接受持续阿片输注≥24小时。
  • 主要终点:11例(12%)发生中度及以上IWS(COWS评定)。
  • IWS阳性组较阴性组阿片输注时间更长、累积剂量更高、日均剂量更高、任一时刻输注速率更高。
  • IWS阳性组右美托咪定使用38.3% vs 阴性组15.6%(p=0.014);苯二氮䓬类63.8% vs 37.8%(p=0.021)。
  • 停药后定期或按需阿片使用两组间无显著差异。
  • 逻辑回归:持续阿片输注≥72小时和日总量≥1200 μg为IWS独立预测因素。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,接受阿片输注≥72小时或芬太尼日总量≥1200 μg(约50 μg/hr)的患者发生IWS风险更高,停用阿片输注时应作为临床实践的一部分进行监测。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Opioids are the mainstay of pain management and sedation in critically ill patients, which can lead to the development of physiologic tolerance and dependency. The prevalence of iatrogenic opioid withdrawal syndrome (IWS) is reported as 17-32% in the ICU; however, limited evidence exists for the medical ICU patient population.

OBJECTIVES: To identify the and risk factors for IWS in adult patients admitted to critical care medicine services who received greater than or equal to 24 hours of continuous opioid infusion therapy.

DESIGN SETTING AND PARTICIPANTS: A prospective, observational study was conducted in a tertiary care hospital in adult medical ICU patients. Ninety-two patients who received greater than or equal to 24 hours of continuous opioid infusions were included in the study.

MAIN OUTCOMES AND MEASUREMENTS: Patients were assessed daily after opioid infusion discontinuation using the Clinical Opiate Withdrawal Scale (COWS) and the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) opioid withdrawal criteria for a maximum of 5 days. The primary outcome was the prevalence of IWS of moderate severity or greater using COWS. Secondary outcomes included the prevalence of IWS diagnosis of any severity based on COWS, the prevalence of IWS diagnosis based on a positive DSM-V score, and the identification of potential risk factors for developing IWS of any severity.

RESULTS: Four hundred forty-seven patients received greater than or equal to 24 hours of continuous opioid therapy. Of these, 385 were excluded, leaving 92 patients included in the final analysis. Except for a higher prevalence of psychiatric history in the IWS-positive group, baseline characteristics were similar. Overall, 11 patients (12%) developed IWS of moderate severity or greater, based on COWS. The IWS-positive group also had longer durations of opioid infusions, higher cumulative opioid infusion doses, higher mean daily doses, and higher infusion rates at any given time. The concomitant use of dexmedetomidine (38.3 vs 15.6%, p = 0.014) and benzodiazepines (63.8 vs 37.8%, p = 0.021) during or after the opioid infusion were significantly higher in the IWS-positive group compared with the IWS-negative group. No significant differences were found between the two groups for scheduled or as needed opioids after cessation of the opioid infusion. Continuous opioid infusions greater than or equal to 72 hours and total daily dose greater than or equal to 1,200 μg were found to be independent predictors for the development of iatrogenic opioid withdrawal via logistic regression.

CONCLUSIONS AND RELEVANCE: Approximately one in every eight patients receiving continuous infusion opioid for greater than 24 hours while mechanically ventilated in the medical ICU will develop IWS of moderate severity or greater; this increases to one in three patients diagnosed with DSM-V criteria or any level of IWS severity. Patients receiving opioid infusions greater than or equal to 72 hours, or a total daily fentanyl dose of greater than or equal to 1,200 μg (~ 50 μg/hr) are at a higher risk for developing IWS and should be monitored as part of clinical practice when opioid infusions are discontinued.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Fox MA, Carothers C, Dircksen KK, et al. Prevalence and Risk Factors for Iatrogenic Opioid Withdrawal in Medical Critical Care Patients. Crit Care Explor. 2023. PMID: 37151892. doi:10.1097/CCE.0000000000000904

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。